Clinical Trial

VZV in the Enteric Nervous System: Pathogenesis and Consequences

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Varicella zoster virus (VZV) is the cause of chickenpox and shingles, but it also infects, becomes latent, and reactivates in nerve cells of the bowel to cause a gastrointestinal disorder ("enteric shingles"). The Investigators recently found that a chronic active VZV infection, a form of enteric shingles, is associated with achalasia, a severe disease in which the passage of food from esophagus to stomach is impaired. We now propose to eradicate VZV to determine whether its association with achalasia is causal, to identify the genetic basis behind VZV reactivation in the esophagus, and the relationship of mast cells to enteric shingles and abdominal pain.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-09-19; most recent amendment 2026-05-22.
Status change: Not Yet Recruiting → Recruiting 2023-03-30
Trial Details
NCT Number NCT05550194
Lead Sponsor Vanderbilt University Medical Center
Collaborators: Columbia University
Conditions Achalasia
Enrollment 40 participants
Start Date 2023-03-27
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-27